• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Up and Coming

Up and Coming

August 24, 2020

This feature highlights changes in clinical trial organizations’ personnel.

Agile Therapeutics

Paul Korner has been appointed chief medical officer of Agile Therapeutics. Most recently, Korner was senior vice president of clinical development and medical affairs at Axovant Gene Therapies.

CorVent Medical

Richard Walsh has been named CEO of Corvent Medical. Walsh was previously vice president of global sales for Medrobotics.

FRISQ

George Thaw has been appointed interim CEO of digital healthcare solutions provider FRISQ. Thaw was most recently CEO of Fuel3D.

Ikena Oncology

Ikena Oncology has named Sergio Santillana chief medical officer. Formerly, Santillana was chief medical officer at Merrimack Pharmaceuticals.

InStep Health

InStep Health has named Lloyd Cochran executive vice president and chief financial officer. Cochran was previously chief operating officer of Bulltech Services. Dan Wilmer, InStep’s chief product officer, has expanded his responsibilities as the company’s new executive vice president.

MiMedX

Robert Stein has been appointed executive vice president of R&D at MiMedX. Stein previously served as senior adviser of R&D at Agenus.

Mind Medicine

Mind Medicine has appointed Miri Wernli as president of the company’s clinical development strategy. Wernli most recently served as CEO of Creso Pharma.

NBE-Therapeutics

NBE-Therapeutics has found its newest CEO in Bertrand Damour, the former CEO of Synthena.

Pacific Biosciences

Pacific Biosciences has named Christian Henry its president and CEO. Henry was previously the chief commercial officer of Illumina.

Paragon Biosciences

Kerensa Jimenez has been named CEO of Paragon Biosciences. Jimenez was most recently a managing director at Octagon Capital Group.

ROME Therapeutics

Dennis Zaller, former executive director of integrative sciences at Celgene, has been named chief scientific officer at ROME Therapeutics.

Seneca Therapeutics

James Hussey has taken the helm at Seneca Therapeutics as the company’s CEO. Hussey joins Seneca from his own consulting company, where he provided C-suite consulting services for biotech and pharma companies.

Slayback Pharma

Slayback Pharma has named Lori Hoffman head of alliance management. Hoffman previously served as senior director of alliance management at Frontida BioPharm.

Swedish Orphan Biovitrum

Ravi Rao has been appointed head of R&D at Swedish Orphan Biovitrum. Rao’s most recent position was as chief medical officer at Aeglea Biotherapeutics.

Tarsus Pharmaceuticals

Tarsus Pharmaceuticals has named Aziz Mottiwala the company’s chief commercial officer. Formerly, Mottiwala was chief commercial officer at Opiant Pharmaceuticals.

TYME Technologies

TYME Technologies has appointed John Rothman to the role of executive vice president of product development. Prior to this appointment, Rothman was director of clinical research at Roche.

ViaCyte

Manasi Jaiman has been appointed vice president of clinical development at ViaCyte. Jaiman previously served as senior medical director at Covance Clinical Development Services.

Werewolf Therapeutics

Ellen Lubman has been hired as chief business officer of Werewolf Therapeutics. Lubman was most recently chief business officer at Impel NeuroPharma.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing